How can we leverage the potential of data to create more value in healthcare? This can be demonstrated by two approaches developed by Air Liquide, which is investing in the field of artificial intelligence as a way to better support hospitals and patients. The Group perfected a system that can predict oxygen consumption patterns in hospitals by combining public Covid-19 data with internal data, allowing for the adjustment of gas production and supply to hospitals. Using data acquired from tracking apnea patients with connected devices, another algorithm identifies the risk of patient non-compliance and therefore how their support can be better preventively adapted.
The pandemic has highlighted the crucial role of medical oxygen for treating patients in respiratory distress. Air Liquide teams, with the help of physicians, are seeking to develop a new non-invasive, ventilation device that is easy to use and can be bulk manufactured. This device would enable to deliver very high rates of oxygen while optimizing consumption and can treat more patients than current devices. In a period of crisis, this is an effective solution when the time of medical professionals and oxygen are in high demand.